We are live on ! Find out more
XPH icon

State Street SPDR S&P Pharmaceuticals ETF

69 hedge funds and large institutions have $332M invested in State Street SPDR S&P Pharmaceuticals ETF in 2014 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 24 increasing their positions, 20 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

20% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 20

16% more capital invested

Capital invested by funds: $287M → $332M (+$45.5M)

6.5% more ownership

Funds ownership: 63.93%70.43% (+6.5%)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

4% less funds holding

Funds holding: 7269 (-3)

23% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 13

Holders
69
Holders Change
-3
Holders Change %
-4.17%
% of All Funds
1.98%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.06%
New
10
Increased
24
Reduced
20
Closed
13
Calls
$218K
Puts
Net Calls
+$218K
Net Calls Change
+$218K
Name Holding Trade Value Shares
Change
Change in
Stake
Citadel Advisors
76
Citadel Advisors
Florida
-$985K -21,040 Closed
AllianceBernstein
77
AllianceBernstein
Tennessee
-$322K -6,888 Closed
WCM
78
Weatherstone Capital Management
Colorado
-$288K -6,148 Closed
AWM
79
Altavista Wealth Management
North Carolina
-$276K -5,906 Closed
CWM
80
Concert Wealth Management
California
-$229K -5,008 Closed
AIM
81
AMI Investment Management
Indiana
-$969K -2,050 Closed
PSC
82
Prentiss Smith & Co
Vermont
-$56K -1,200 Closed